Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system

Schmidt M, Degenhardt T, Fasching P, Lueftner D, Mueller V, Thomssen C, Schem C, Witzel I, Decker T, Tesch H, Kuemmel S, Uleer C, Wuerstlein R, Hoffmann O, Warm M, Marschner N, Kates RE, Schumacher J, Harbeck N (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

European Journal of Cancer Elsevier

Publisher: ELSEVIER SCI LTD

City/Town: OXFORD

Pages Range: S68-S68

Conference Proceedings Title: EUROPEAN JOURNAL OF CANCER

DOI: 10.1016/s0959-8049(20)30709-7

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Krankenhaus Jerusalem

Germany (DE) Martin-Luther-Universität Halle-Wittenberg (MLU)

Germany (DE) Ludwig-Maximilians-Universität (LMU)

Germany (DE) Universitätsklinikum Essen

Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE)

Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Germany (DE) Krankenhaus Köln-Holweide

Germany (DE) palleos healthcare GmbH

Germany (DE) Charité - Universitätsmedizin Berlin

Germany (DE) Westdeutsche Studiengruppe GmbH (WSG) / Women's healthcare Study Group

Germany (DE) iOMEDICO AG

Germany (DE) Kliniken Essen-Mitte

Germany (DE)

How to cite

APA:

Schmidt, M., Degenhardt, T., Fasching, P., Lueftner, D., Mueller, V., Thomssen, C.,... Harbeck, N. (2020). Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system. In EUROPEAN JOURNAL OF CANCER (pp. S68-S68). OXFORD: ELSEVIER SCI LTD.

MLA:

Schmidt, M., et al. "Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system." Proceedings of the 12th European Breast Cancer Conference (EBCC) OXFORD: ELSEVIER SCI LTD, 2020. S68-S68.

BibTeX: Download